Share Price and Basic Stock Data
Last Updated: November 10, 2025, 11:07 pm
| PEG Ratio | -1.47 |
|---|
Analyst Insight & Comprehensive Analysis
Business Overview and Revenue Trends
Ambo Agritec Ltd operates within the Edible Oils and Solvent Extraction industry, reporting a price of ₹58.9 and a market capitalization of ₹91.2 Cr. The company has shown a varied revenue performance over recent years. For the fiscal year ending March 2025, Ambo Agritec recorded sales of ₹120 Cr, representing growth from ₹81 Cr in the previous year. The quarterly sales figures indicate a positive trajectory, with ₹59 Cr in March 2024, up from ₹42 Cr in September 2023. However, the company faced a decline to ₹52 Cr in September 2024, before rebounding to ₹68 Cr in March 2025. This fluctuation in sales reflects the challenges within the edible oils sector, where market dynamics can significantly impact revenue streams. The operating profit margin (OPM) has been relatively low, standing at 2% in March 2024 and declining to 0% in March 2025, indicating potential operational inefficiencies that need addressing.
Profitability and Efficiency Metrics
Ambo Agritec’s profitability has been constrained, as evidenced by a net profit of only ₹2 Cr for the fiscal year ending March 2025. The net profit margin has decreased from 1.35% in March 2024 to 1.01% in March 2025, highlighting profitability challenges. The company’s return on equity (ROE) stood at 6.24%, which is relatively low compared to sector standards, suggesting that shareholder returns may not be maximized effectively. Additionally, the operating profit margin (OPM) recorded a peak of 5% in September 2024, yet fell to 0% by March 2025, reflecting operational challenges. The cash conversion cycle (CCC) has extended significantly, reaching 119 days by March 2025, which is considerably higher than typical industry ranges, indicating inefficiencies in managing working capital. These metrics collectively suggest that while Ambo Agritec is generating sales, translating these into profits remains a significant hurdle.
Balance Sheet Strength and Financial Ratios
Ambo Agritec’s balance sheet reflects a modest financial position, with total borrowings of ₹16 Cr and reserves of ₹28 Cr as of March 2025. The company’s debt-to-equity ratio stands at 0.38, indicating a conservative leverage position, which is favorable compared to typical sector norms. However, the interest coverage ratio (ICR) of 2.36x suggests that the company has a limited buffer to cover interest obligations, which could be a concern if earnings do not improve. The book value per share increased from ₹19.45 in March 2024 to ₹28.68 in March 2025, indicating growth in net worth per share. Furthermore, the current ratio of 2.94x reflects a strong liquidity position, suggesting that Ambo Agritec can comfortably meet its short-term obligations. Overall, while the company has a solid liquidity position, its profitability metrics and operational efficiencies need substantial improvement.
Shareholding Pattern and Investor Confidence
The shareholding pattern of Ambo Agritec demonstrates a strong promoter presence, holding 61.05% as of March 2025, indicating significant insider confidence in the company. The public holds 38.95%, while foreign institutional investors (FIIs) and domestic institutional investors (DIIs) hold negligible stakes of 0.00% and 0.01%, respectively. This lack of institutional interest may reflect concerns regarding the company’s profitability and operational efficiency. The number of shareholders has fluctuated, declining from 565 in March 2023 to 317 by March 2025, indicating potential disenchantment among smaller investors. This trend may impact liquidity and market perception. The high promoter holding could also suggest a commitment to long-term growth, but the low institutional interest may hinder broader market confidence and investment appeal.
Outlook, Risks, and Final Insight
Ambo Agritec faces a mixed outlook, characterized by growth potential in revenues but significant operational and profitability challenges. The company’s fluctuating sales figures and declining profit margins raise concerns about its ability to sustain growth amid competitive pressures in the edible oils sector. Key risks include the extended cash conversion cycle, which may strain liquidity, and the low interest from institutional investors, potentially limiting access to capital. Strengths lie in the solid promoter backing and a conservative balance sheet, providing a foundation for future growth. However, the company must address its operational inefficiencies and enhance profitability metrics to attract broader investor confidence. If Ambo Agritec can leverage its strong liquidity position to improve operational performance, there is potential for recovery and growth; conversely, failure to address these issues may lead to continued financial strain and reduced market attractiveness.
Source: Getaka Fundamental Analysis | Generated using proprietary financial data.
Competitors of Ambo Agritec Ltd
| Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
|---|---|---|---|---|---|---|---|---|---|
| Modi Naturals Ltd | 552 Cr. | 422 | 667/320 | 16.2 | 92.8 | 0.00 % | 18.7 % | 29.2 % | 10.0 |
| IEL Ltd | 106 Cr. | 8.10 | 10.3/3.87 | 3.44 | 0.00 % | 2.51 % | 1.91 % | 1.00 | |
| Evexia Lifecare Ltd | 329 Cr. | 1.75 | 4.40/1.65 | 188 | 2.45 | 0.00 % | 0.30 % | 0.32 % | 1.00 |
| Diligent Industries Ltd | 62.2 Cr. | 2.61 | 5.12/1.45 | 23.1 | 2.71 | 0.00 % | 7.06 % | 6.09 % | 1.00 |
| CIAN Agro Industries & Infrastructure Ltd | 4,711 Cr. | 1,684 | 3,633/293 | 5,415 | 32.8 | 0.00 % | 8.54 % | 1.06 % | 10.0 |
| Industry Average | 9,844.40 Cr | 196.09 | 356.01 | 35.81 | 0.17% | 14.31% | 12.90% | 4.29 |
Quarterly Result
| Metric | Sep 2023 | Mar 2024 | Sep 2024 | Mar 2025 |
|---|---|---|---|---|
| Sales | 42 | 59 | 52 | 68 |
| Expenses | 40 | 58 | 49 | 68 |
| Operating Profit | 1 | 1 | 3 | 0 |
| OPM % | 4% | 2% | 5% | 0% |
| Other Income | 0 | 1 | 0 | 2 |
| Interest | 1 | 1 | 1 | 1 |
| Depreciation | 0 | 0 | 0 | 0 |
| Profit before tax | 1 | 1 | 2 | 1 |
| Tax % | 25% | 31% | 25% | 52% |
| Net Profit | 1 | 1 | 1 | 0 |
| EPS in Rs | 0.57 | 0.92 | 1.26 | 0.33 |
Last Updated: May 31, 2025, 7:02 am
Below is a detailed analysis of the quarterly data for Ambo Agritec Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:
- For Sales, as of Mar 2025, the value is 68.00 Cr.. The value appears strong and on an upward trend. It has increased from 52.00 Cr. (Sep 2024) to 68.00 Cr., marking an increase of 16.00 Cr..
- For Expenses, as of Mar 2025, the value is 68.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 49.00 Cr. (Sep 2024) to 68.00 Cr., marking an increase of 19.00 Cr..
- For Operating Profit, as of Mar 2025, the value is 0.00 Cr.. The value appears to be declining and may need further review. It has decreased from 3.00 Cr. (Sep 2024) to 0.00 Cr., marking a decrease of 3.00 Cr..
- For OPM %, as of Mar 2025, the value is 0.00%. The value appears to be declining and may need further review. It has decreased from 5.00% (Sep 2024) to 0.00%, marking a decrease of 5.00%.
- For Other Income, as of Mar 2025, the value is 2.00 Cr.. The value appears strong and on an upward trend. It has increased from 0.00 Cr. (Sep 2024) to 2.00 Cr., marking an increase of 2.00 Cr..
- For Interest, as of Mar 2025, the value is 1.00 Cr.. The value remains steady. There is no change compared to the previous period (Sep 2024) which recorded 1.00 Cr..
- For Depreciation, as of Mar 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Sep 2024) which recorded 0.00 Cr..
- For Profit before tax, as of Mar 2025, the value is 1.00 Cr.. The value appears to be declining and may need further review. It has decreased from 2.00 Cr. (Sep 2024) to 1.00 Cr., marking a decrease of 1.00 Cr..
- For Tax %, as of Mar 2025, the value is 52.00%. The value appears to be increasing, which may not be favorable. It has increased from 25.00% (Sep 2024) to 52.00%, marking an increase of 27.00%.
- For Net Profit, as of Mar 2025, the value is 0.00 Cr.. The value appears to be declining and may need further review. It has decreased from 1.00 Cr. (Sep 2024) to 0.00 Cr., marking a decrease of 1.00 Cr..
- For EPS in Rs, as of Mar 2025, the value is 0.33. The value appears to be declining and may need further review. It has decreased from 1.26 (Sep 2024) to 0.33, marking a decrease of 0.93.
Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.
Profit & Loss - Annual Report
Last Updated: June 16, 2025, 3:01 pm
| Metric | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|
| Sales | 63 | 73 | 47 | 95 | 81 | 101 | 120 |
| Expenses | 62 | 73 | 46 | 92 | 78 | 98 | 117 |
| Operating Profit | 1 | 0 | 1 | 3 | 2 | 3 | 3 |
| OPM % | 2% | 1% | 3% | 3% | 3% | 3% | 2% |
| Other Income | 1 | 1 | 0 | 0 | 1 | 1 | 2 |
| Interest | 1 | 1 | 1 | 1 | 1 | 2 | 2 |
| Depreciation | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit before tax | 0 | 0 | 0 | 2 | 2 | 2 | 3 |
| Tax % | 16% | -10% | 34% | 38% | 25% | 28% | 35% |
| Net Profit | 0 | 0 | 0 | 1 | 1 | 1 | 2 |
| EPS in Rs | 24.60 | 18.31 | 10.87 | 68.08 | 1.26 | 1.49 | 1.30 |
| Dividend Payout % | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
YoY Net Profit Growth
| Year | 2022-2023 | 2023-2024 | 2024-2025 |
|---|---|---|---|
| YoY Net Profit Growth (%) | 0.00% | 0.00% | 100.00% |
| Change in YoY Net Profit Growth (%) | 0.00% | 0.00% | 100.00% |
Ambo Agritec Ltd has shown a consistent positive trend in YoY Net Profit Growth (%) in the last 3 years from 2022-2023 to 2024-2025.
Growth
| Compounded Sales Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | 10% |
| 3 Years: | 8% |
| TTM: | 19% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | 43% |
| 3 Years: | 17% |
| TTM: | 36% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| 1 Year: | -56% |
| Return on Equity | |
|---|---|
| 10 Years: | % |
| 5 Years: | 9% |
| 3 Years: | 8% |
| Last Year: | 6% |
Last Updated: September 5, 2025, 2:16 pm
No data available for the Balance Sheet data table.
Cash Flow - No data available for this post.
Financial Efficiency Indicators
| Month | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|
| Debtor Days | 19 | 25 | 21 | 12 | 62 | 45 | 74 |
| Inventory Days | 69 | 52 | 88 | 56 | 73 | 80 | 65 |
| Days Payable | 41 | 37 | 54 | 17 | 30 | 23 | 20 |
| Cash Conversion Cycle | 47 | 41 | 55 | 51 | 105 | 102 | 119 |
| Working Capital Days | 13 | 11 | 31 | 5 | 71 | 59 | 133 |
| ROCE % | 11% | 10% | 21% | 13% | 11% | 10% |
This stock is not held by any mutual fund.
Key Financial Ratios
| Month | Mar 25 | Mar 24 |
|---|---|---|
| FaceValue | 10.00 | 10.00 |
| Basic EPS (Rs.) | 1.10 | 1.45 |
| Diluted EPS (Rs.) | 1.10 | 1.45 |
| Cash EPS (Rs.) | 0.90 | 1.55 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 28.68 | 19.45 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 28.68 | 19.45 |
| Revenue From Operations / Share (Rs.) | 81.30 | 107.62 |
| PBDIT / Share (Rs.) | 2.75 | 3.77 |
| PBIT / Share (Rs.) | 2.68 | 3.68 |
| PBT / Share (Rs.) | 1.51 | 2.05 |
| Net Profit / Share (Rs.) | 0.82 | 1.45 |
| NP After MI And SOA / Share (Rs.) | 0.83 | 1.45 |
| PBDIT Margin (%) | 3.38 | 3.50 |
| PBIT Margin (%) | 3.29 | 3.41 |
| PBT Margin (%) | 1.85 | 1.90 |
| Net Profit Margin (%) | 1.01 | 1.35 |
| NP After MI And SOA Margin (%) | 1.02 | 1.35 |
| Return on Networth / Equity (%) | 2.91 | 7.47 |
| Return on Capital Employeed (%) | 8.84 | 15.61 |
| Return On Assets (%) | 1.83 | 3.30 |
| Long Term Debt / Equity (X) | 0.04 | 0.12 |
| Total Debt / Equity (X) | 0.38 | 0.80 |
| Asset Turnover Ratio (%) | 2.21 | 0.00 |
| Current Ratio (X) | 2.94 | 1.85 |
| Quick Ratio (X) | 2.07 | 0.79 |
| Inventory Turnover Ratio (X) | 6.03 | 0.00 |
| Interest Coverage Ratio (X) | 2.36 | 2.32 |
| Interest Coverage Ratio (Post Tax) (X) | 1.71 | 1.89 |
| Enterprise Value (Cr.) | 138.76 | 36.09 |
| EV / Net Operating Revenue (X) | 1.16 | 0.35 |
| EV / EBITDA (X) | 34.22 | 10.18 |
| MarketCap / Net Operating Revenue (X) | 1.03 | 0.21 |
| Price / BV (X) | 2.91 | 1.18 |
| Price / Net Operating Revenue (X) | 1.03 | 0.21 |
| EarningsYield | 0.01 | 0.06 |
After reviewing the key financial ratios for Ambo Agritec Ltd, here is a detailed analysis based on the latest available data and recent trends:
- For FaceValue, as of Mar 25, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 10.00.
- For Basic EPS (Rs.), as of Mar 25, the value is 1.10. This value is below the healthy minimum of 5. It has decreased from 1.45 (Mar 24) to 1.10, marking a decrease of 0.35.
- For Diluted EPS (Rs.), as of Mar 25, the value is 1.10. This value is below the healthy minimum of 5. It has decreased from 1.45 (Mar 24) to 1.10, marking a decrease of 0.35.
- For Cash EPS (Rs.), as of Mar 25, the value is 0.90. This value is below the healthy minimum of 3. It has decreased from 1.55 (Mar 24) to 0.90, marking a decrease of 0.65.
- For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 28.68. It has increased from 19.45 (Mar 24) to 28.68, marking an increase of 9.23.
- For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 28.68. It has increased from 19.45 (Mar 24) to 28.68, marking an increase of 9.23.
- For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 81.30. It has decreased from 107.62 (Mar 24) to 81.30, marking a decrease of 26.32.
- For PBDIT / Share (Rs.), as of Mar 25, the value is 2.75. This value is within the healthy range. It has decreased from 3.77 (Mar 24) to 2.75, marking a decrease of 1.02.
- For PBIT / Share (Rs.), as of Mar 25, the value is 2.68. This value is within the healthy range. It has decreased from 3.68 (Mar 24) to 2.68, marking a decrease of 1.00.
- For PBT / Share (Rs.), as of Mar 25, the value is 1.51. This value is within the healthy range. It has decreased from 2.05 (Mar 24) to 1.51, marking a decrease of 0.54.
- For Net Profit / Share (Rs.), as of Mar 25, the value is 0.82. This value is below the healthy minimum of 2. It has decreased from 1.45 (Mar 24) to 0.82, marking a decrease of 0.63.
- For NP After MI And SOA / Share (Rs.), as of Mar 25, the value is 0.83. This value is below the healthy minimum of 2. It has decreased from 1.45 (Mar 24) to 0.83, marking a decrease of 0.62.
- For PBDIT Margin (%), as of Mar 25, the value is 3.38. This value is below the healthy minimum of 10. It has decreased from 3.50 (Mar 24) to 3.38, marking a decrease of 0.12.
- For PBIT Margin (%), as of Mar 25, the value is 3.29. This value is below the healthy minimum of 10. It has decreased from 3.41 (Mar 24) to 3.29, marking a decrease of 0.12.
- For PBT Margin (%), as of Mar 25, the value is 1.85. This value is below the healthy minimum of 10. It has decreased from 1.90 (Mar 24) to 1.85, marking a decrease of 0.05.
- For Net Profit Margin (%), as of Mar 25, the value is 1.01. This value is below the healthy minimum of 5. It has decreased from 1.35 (Mar 24) to 1.01, marking a decrease of 0.34.
- For NP After MI And SOA Margin (%), as of Mar 25, the value is 1.02. This value is below the healthy minimum of 8. It has decreased from 1.35 (Mar 24) to 1.02, marking a decrease of 0.33.
- For Return on Networth / Equity (%), as of Mar 25, the value is 2.91. This value is below the healthy minimum of 15. It has decreased from 7.47 (Mar 24) to 2.91, marking a decrease of 4.56.
- For Return on Capital Employeed (%), as of Mar 25, the value is 8.84. This value is below the healthy minimum of 10. It has decreased from 15.61 (Mar 24) to 8.84, marking a decrease of 6.77.
- For Return On Assets (%), as of Mar 25, the value is 1.83. This value is below the healthy minimum of 5. It has decreased from 3.30 (Mar 24) to 1.83, marking a decrease of 1.47.
- For Long Term Debt / Equity (X), as of Mar 25, the value is 0.04. This value is below the healthy minimum of 0.2. It has decreased from 0.12 (Mar 24) to 0.04, marking a decrease of 0.08.
- For Total Debt / Equity (X), as of Mar 25, the value is 0.38. This value is within the healthy range. It has decreased from 0.80 (Mar 24) to 0.38, marking a decrease of 0.42.
- For Asset Turnover Ratio (%), as of Mar 25, the value is 2.21. It has increased from 0.00 (Mar 24) to 2.21, marking an increase of 2.21.
- For Current Ratio (X), as of Mar 25, the value is 2.94. This value is within the healthy range. It has increased from 1.85 (Mar 24) to 2.94, marking an increase of 1.09.
- For Quick Ratio (X), as of Mar 25, the value is 2.07. This value exceeds the healthy maximum of 2. It has increased from 0.79 (Mar 24) to 2.07, marking an increase of 1.28.
- For Inventory Turnover Ratio (X), as of Mar 25, the value is 6.03. This value is within the healthy range. It has increased from 0.00 (Mar 24) to 6.03, marking an increase of 6.03.
- For Interest Coverage Ratio (X), as of Mar 25, the value is 2.36. This value is below the healthy minimum of 3. It has increased from 2.32 (Mar 24) to 2.36, marking an increase of 0.04.
- For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 1.71. This value is below the healthy minimum of 3. It has decreased from 1.89 (Mar 24) to 1.71, marking a decrease of 0.18.
- For Enterprise Value (Cr.), as of Mar 25, the value is 138.76. It has increased from 36.09 (Mar 24) to 138.76, marking an increase of 102.67.
- For EV / Net Operating Revenue (X), as of Mar 25, the value is 1.16. This value is within the healthy range. It has increased from 0.35 (Mar 24) to 1.16, marking an increase of 0.81.
- For EV / EBITDA (X), as of Mar 25, the value is 34.22. This value exceeds the healthy maximum of 15. It has increased from 10.18 (Mar 24) to 34.22, marking an increase of 24.04.
- For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 1.03. This value is within the healthy range. It has increased from 0.21 (Mar 24) to 1.03, marking an increase of 0.82.
- For Price / BV (X), as of Mar 25, the value is 2.91. This value is within the healthy range. It has increased from 1.18 (Mar 24) to 2.91, marking an increase of 1.73.
- For Price / Net Operating Revenue (X), as of Mar 25, the value is 1.03. This value is within the healthy range. It has increased from 0.21 (Mar 24) to 1.03, marking an increase of 0.82.
- For EarningsYield, as of Mar 25, the value is 0.01. This value is below the healthy minimum of 5. It has decreased from 0.06 (Mar 24) to 0.01, marking a decrease of 0.05.
Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.
Strength and Weakness
Unable to fetch valid data for stock valuation.Stock Analysis
- Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Ambo Agritec Ltd:
- Net Profit Margin: 1.01%
- Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
- ROCE: 8.84% (Industry Average ROCE: 14.31%)
- ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
- ROE%: 2.91% (Industry Average ROE: 12.29%)
- ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
- Interest Coverage Ratio (Post Tax): 1.71
- Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
- Quick Ratio: 2.07
- Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
- Stock P/E: 51 (Industry average Stock P/E: 288.2)
- Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
- Total Debt / Equity: 0.38
- Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
Stock Rating: - Net Profit Margin: 1.01%

